Charlton Aria Acquisition Corp

Exchange listing compliance directly governs public market access, shareholder liquidity, and the practical feasibility of completing a deSPAC transaction before termination. The delinquent periodic reports eliminate near-term financial transparency, leaving investors unable to verify trust account interest accumulation, administrative expense drawdowns, or sponsor promissory note status. A missed June 15, 2026, filing or a subsequent Nasdaq Hearings Panel rejection would likely trigger forced delisting to an over-the-counter or alternative quotation venue, which typically compresses trading spreads, raises redemption friction, and heightens pressure to liquidate prior to the fixed October 25, 2026 deadline rather than execute a merger.

For investors tracking redemption windows, trust value stability, and sponsor conduct, cumulative reporting lapses increase compliance visibility and may constrain the sponsor's ability to execute a merger within the remaining timeframe. Rule 12b-25 relief prevents immediate trading halts or delisting actions for the specific quarter, but it carries no extension to the charter's business combination period and offers no protection against shareholder redemptions triggered after October 25, 2026. The filing contains zero operational substance: Chief Executive Officer Jung Min Lee makes no claims about customers, revenue, market size, strategy, technology, partnerships, or litigation, and there are no updates regarding sponsor equity allocations, lock-up terms, or changes to redemption mechanics.

This filing materially adjusts the redemption calendar by pushing the liquidation trigger back three months to July 25, 2026, altering the timeframe in which public shareholders may exercise redemption rights before a forced dissolution deadline. It confirms continued sponsor financial engagement ($850,000 funded plus $500,000 in standby working capital credit) structured as non-dilutive senior debt, while establishing explicit conversion mechanics that allocate equity upside to the sponsor only upon a successful combination. Because the April 27, 2026 press release states the registrant remains a blank check company with search parameters limited only to a lack of industry or geographic restriction, the extension preserves strategic options rather than indicating deal execution. All monetary amounts, interest accrual triggers, conversion caps, maturity events, and waiver language derive exclusively from the Company’s 8-K text, the filed promissory note provisions, and statements attributed to CEO Jung Min Lee and the Sponsor.

While the notice explicitly states there is no immediate effect on listing or trading and leaves the registered liquidation deadline of October 25, 2026, untouched, the missing 10-K creates opacity for shareholders tracking redemption conditions and trust preservation ahead of the statutory wind-down. Chairman and Chief Executive Officer Jung Min Lee stated the Company intends to file the Form 10-K "as promptly as possible," adding that if the filing is not made by June 15, 2026, the Company will formally submit a compliance plan with Nasdaq. Prolonged administrative noncompliance heightens secondary delisting risk, which can constrain market maker participation and unit liquidity well ahead of the redemption window, even if the Nasdaq-approved extension timeline theoretically aligns with the default termination date. No target acquisition, merger agreement, or sponsor amendment has been announced in this filing.

Administrative delays in finalizing annual financials do not alter the redemption calendar or trust valuation, but they can signal internal accounting bottlenecks, deferred auditor reviews, or ongoing resource constraints while the SPAC remains in SEARCHING status. Because this is purely a late-filing notification, it contains zero substantive commercial disclosures: there are no claims about customers, revenue streams, addressable market size, acquisition targets, technology pipelines, strategic partnerships, litigation exposure, or sponsor governance metrics. The only operational takeaway is executive acknowledgment of internal assembly delays and a commitment to near-term compliance. Investors must await the actual 10-K contents to verify cash positions, related-party transaction disclosures, and audit readiness as the company navigates toward its October 25, 2026 sunset deadline.

While executive succession alters board and C-suite composition, the filing explicitly preserves the existing capital structure parameters: the trust remains valued at $10.81 per share and the liquidation deadline is firmly set for 2026-10-25. Mr. Lee is formally disclosed as neither a promoter nor a control person, clarifying his standing relative to the SPAC's redemption mechanics. For investors tracking sponsor conduct, the primary watch item is the timeline for recruiting a permanent, full-time Chief Financial Officer, as Mr. Lee currently covers that function only in an interim capacity.

For investors tracking redemption deadlines, trust value preservation, extension mechanics, and sponsor conduct, this leadership turnover directly impacts execution timelines ahead of the stated liquidation cutoff. Because the company remains in a pre-deal, target-search phase without a seated chairman or chief executive operator, the remaining independent directors and CFO now hold sole fiduciary oversight. The absence of a dispute declaration means the filings do not trigger mandatory redemption windows, amend the business combination agreement, or alter warrant exercisability or trust distribution math. However, advancing toward a definitive merger agreement, negotiating lock-up and PIPE terms, or preparing an extension vote will require accelerated internal approvals. Until successors are appointed, the sponsor’s ability to marshal shareholder votes or manage redemption pacing rests with a truncated board, elevating operational friction risk but preserving existing economic terms and shareholder rights exactly as originally disclosed.

This filing is material. It confirms the SPAC remains in a cash-burn stage with virtually no cash outside the trust to fund operations and search costs. The net positive income is entirely from trust yield, not operations. The sponsor change is a significant governance and conduct event that investors should track for potential changes in strategy or commitment. The going concern warning is reinforced. Redemption math is unchanged: trust value per share has grown to $10.42 from the IPO's $10.025 base, but any shareholder considering redemption should note the current trust-per-share figure ($10.42) when assessing total return. No extension has been made yet; the first deadline is approximately 5 months from this filing date.

Investors need to track trust value, redemption price, cash burn, and the new sponsor (Sovereign Global Trust) ahead of the April 2026 deadline. The sponsor change may affect deal prospects and ability to extend.

Beyond the mechanics, the registrant explicitly warns that the new sponsorship structure means it “may be considered a foreign person” under Committee on Foreign Investment in the United States (CFIUS) rules. According to the filing, this classification could prevent the company from completing an initial business combination with a U.S. target if such transactions become subject to federal foreign investment regulations, review, or prohibition. The company references its final prospectus filed October 24, 2024 (page 70), stating that the resulting “pool of potential targets with which we could complete an initial business combination may be limited.” This introduces direct regulatory friction into the deal-search strategy without altering the per-share trust value or termination schedule, fundamentally changing the execution risk profile for public shareholders monitoring sponsor conduct and completion timelines.

The sponsor change is a material development for investors tracking sponsor conduct and the likelihood of deal completion. A new sponsor taking over with $4 million in cash indicates a strong commitment to funding potential extension payments (up to $1,750,000) and pursuing a business combination. The trust value has grown to $86,769,326, implying a per-share redemption value of $10.21 as of March 31, 2025. The report also reaffirms the April 25, 2026 deadline, with the ability to extend to October 25, 2026.

Provides baseline financials and trust value; confirms no near-term deal; highlights internal control weakness that could affect trust accounting; though no new risk, confirms SPAC is proceeding as expected with no deviation.

Establishes the per-share trust value ($10.025) and the redemption deadline (April 25, 2026, with possible extensions). Investors tracking redemption timing and trust value need this baseline. Discloses sponsor conduct (founder share transfers, insider voting/lock-up agreements) and internal control weaknesses that may affect deal execution.

This filing establishes the key terms and financial mechanics for a newly-public SPAC, including the trust account (at least $10.025 per unit), extension terms (up to two 3-month extensions for $750,000 each, or $862,500 if over-allotment exercised in full), redemption rights of public shareholders, and the sponsor's compensation structure. The going concern disclosure highlights the risk of dissolution if no business combination is completed by the deadline. The subsequent events disclose crucial post-balance sheet developments regarding the IPO and over-allotment that affect the company's capital structure and trust account balance.

Investors tracking the redemption calendar note no change to the October 25, 2026 deadline, but the trust account now holds $85,212,500 backing the expanded 8,500,000 public share pool, preserving the per-share cash position until a merger occurs. The near-complete closure of the over-allotment option stabilizes the capitalization table, reduces pending underwriting liabilities, and removes a short-term variable from share count projections. Sponsor conduct remains aligned, as ST Sponsor II Limited again purchased private units at the standard $10.00 price, matching public terms without altering redemption mechanics. The $1,700,000 deferred underwriting fee represents a fixed post-combination payout obligation that does not affect current operational liquidity or extension math. According to the press release dated November 19, 2024, leadership contact points to Mr. Robert W. Garner as Chairman, Chief Executive Officer, and Director, with Robinson & Cole LLP and Winston & Strawn LLP named as legal counsel. The filing confirms search efforts are unrestricted by industry or geography, but discloses zero details regarding specific targets, revenue projections, technology partnerships, customer pipelines, or ongoing litigation.

It precisely maps Whitebox’s voting footprint (399,000 shares exercisable only with shared authority), clarifying that any influence over redemption elections, extension approvals, or business combination votes would require coalition-building rather than unilateral action. The explicit non-control certification signals a passive investment posture, indicating investors should not anticipate near-term pressure on the liquidation timeline or adjustments to the trust account based on this holder’s activity alone.

This filing fixes the exact trust balance at $75,187,500, sets the hard redemption deadline of April 25, 2026, and codifies the sponsor extension funding mechanics ($750,000/$862,500 per extension). Management disclosed $850,268 in unrestricted cash against a working deficit of $21,087 and current liabilities totaling $886,155, alongside $354,363 in other offering costs and total transaction costs of $3,060,711. The Sponsor agreed to liability obligations to prevent the trust from falling below the lesser of $10.025 per public share or the actual per-share trust balance at liquidation, though the auditor explicitly noted the sponsor's only assets appear to be company securities, highlighting potential enforceability risk regarding third-party claims. Regarding personnel and sponsor conduct, the notes disclose that founder shares were transferred to Chairman/CEO Will Garner (100,000 shares) and CFO Yuanmei Ma (60,000 shares) for $1,855 total (~$0.0116 per share), generating $185,345 in recognized stock compensation, while 60,000 shares were allocated to three independent directors for $696, generating $64,350 in compensation. Garner and Ma are contractually owed fixed annual cash compensation of $7,500 and $5,000, respectively. A related-party promissory note of $273,969 was repaid on October 30, 2024, and up to $3,000,000 in working capital loans remain available but unsubscribed. With zero operating revenues and explicit management disclaimers that 'there is no assurance that the Company will be able to complete a Business Combination successfully,' tracking the extension deposit schedule and any subsequent target announcements against the April 25, 2026 cutoff is essential for assessing redemption timelines and capital preservation.

SPAC is now publicly traded with a fresh trust of ~$10.81 per share. The three new directors – all independent – hold small Class B stakes and may serve as a check on sponsor conduct. The charter includes a 15% cap on any group's aggregate redemption rights without company consent. Investors should track any extension votes, deal announcements or charter amendments; the sponsor's lock-up on founder shares (50% for 6 months or $12.50 trigger, 50% for full 6 months) is standard.

This document defines all key SPAC mechanics for investors: trust value per share ($10.025), redemption rights, deadline (18-24 months), extension terms, sponsor economics (nominal purchase price for founder shares creates dilution), and potential conflicts of interest. It is the primary source for assessing the attractiveness of the offering and the sponsor's alignment with public shareholders.

The increased trust deposit and earlier issuance of representative shares improve trust per share for public investors. The two optional extensions (up to 24 months) reduce immediate liquidation risk and give more time to find a target. Sponsor loans and private unit purchases signal alignment, but the going concern qualification and ongoing derivative litigation against a director nominee add risk. No business combination target has been identified; the SPAC remains in searching status.

Investors tracking cash runway and pre-deal spending should note that nearly half of the non-trust reserve ($287,500 out of $600,000) is contractually committed to fixed executive salaries through 18 months post-closing. Because these payouts drain the $600,000 working capital bucket rather than the trust account, they do not reduce the per-share amount available for redemptions but accelerate the depletion of operating funds needed for due diligence, regulatory compliance, and potential extension financing. The SEC’s targeted inquiry indicates regulators are scrutinizing whether management salaries functionally operate as sponsorship carry or deferred offering costs that should be capitalized rather than expensed. The disclosed reliance on sponsor loans up to $3,000,000 and the explicit warning that actual legal/accounting costs may exceed projections highlight balance sheet flexibility constraints. Shareholders monitoring whether the SPAC can complete a business combination by its 2026-10-25 deadline should watch for subsequent quarterly reports detailing actual draws against the $600,000 allocation, any amendment to the D&O premium once finalized, and whether the 18-month post-closing salary term creates pressure to close rapidly once a target is identified.

Because the SPAC is pre-IPO, redemptions, extension votes, and deal progress are not yet applicable. However, the trust value of $10.025 per unit is now confirmed. The filing discloses sponsor compensation: the CEO receives $7,500/month and the CFO $5,000/month. It also discloses conflict-of-interest risks, including that sponsor's sole member, a Malaysian resident, may trigger CFIUS review of any U.S. target, limiting the pool of potential deals. The sponsor also controls a second SPAC, creating potential competition for targets.

The acceleration request signals active capital-markets administration while the SPAC remains in SEARCHING status. For investors tracking the October 25, 2026 horizon, an advanced S-1 filing typically precedes new unit, share, or warrant registrations, PIPE commitments, or over-allotment exercises that may interact with the existing trust prior to a de-SPAC transaction. The letter copies Arila E. Zhou, Esq. of Robinson & Cole LLP, indicating standard external legal routing for securities filings. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive personnel changes.

This filing establishes the mechanics for a new SPAC with a trust value of $10.025 per share and a 2026-10-25 deadline (18 months from expected closing). Investors should note the high dilution from sponsor shares purchased at $0.0116 per share and the CFIUS risk due to Malaysian sponsor control. The document confirms no substantive discussions with any target have occurred.

What changed: A Current Report on Form 8-K filed under Item 8.01 Other Events announcing the closing of a Nasdaq Global Market listing compliance investigation. Nothing has altered the CHAR redemption timeline, trust mechanics, or extension posture. As detailed in the filing, The Nasdaq Stock Market LLC notified the Company on April 16, 2026, that it violated Nasdaq Listing Rule 5250(c)(1) for missing the filing window for its Annual Report on Form 10-K covering the fiscal year ended December 31, 2025. The Company submitted that 10-K on May 28, 2026, yet remained non-compliant until delivering its Quarterly Report on Form 10-Q for the period ended March 31, 2026 on June 17, 2026. Per a letter dated June 23, 2026, Nasdaq confirmed compliance and closed the matter. The filing makes no adjustments to the existing SPAC structural timeline or capital account. Why it matters: Repeated periodic-reporting delays signal administrative execution friction, which sponsors and deal trackers monitor as potential signals of diluting or delaying a merger. The filing contains zero claims regarding customer concentration, revenue streams, addressable market size, proprietary technology, commercial partnerships, ongoing litigation, or executive compensation changes. Chief Executive Officer Jung Min Lee executed the June 26, 2026 attestation confirming the Nasdaq resolution. Because the submission isolates purely regulatory remediation without financial or commercial metrics, investors should treat it as a listing-status preservation event that clears an immediate delisting hurdle but underscores operational lag ahead of the unmodified business combination deadline.

What changed: 10-Q quarterly report. The filing shows no deal announcement. Trust per share went to $10.62 from $10.52 due to interest income. The original 18-month deadline of April 25, 2026 was extended: on April 24, 2026, the sponsor deposited $850,000 to extend the deadline to July 25, 2026. Both the former CEO Will Garner (resigned Feb. 4, 2026) and former CFO Yuanmei Ma (resigned March 26, 2026) have left. The CEO/acting CFO position was filled by Jung Min Lee on March 26, 2026. The company had only $4,597 of cash and a $271,825 working capital deficit as of March 31, 2026, and management expresses substantial doubt about the company's ability to continue as a going concern. A new $500,000 working capital loan was agreed on April 17, 2026; about $0.3 million was drawn. Disclosure controls were not effective. Why it matters: The trust value is $10.62 per share, but the company has $4,597 in cash and a $271,825 working capital deficit, leading to a going concern warning. The CEO and CFO both resigned in early 2026 and were replaced by Jung Min Lee, who is now acting CFO. The sponsor extended the deadline to July 25, 2026, by depositing $850,000, but the company has no announced target and is burning cash. The company has not filed its reports on time (No to Entity Current Reporting Status), disclosure controls are ineffective, and it is a shell company. These points suggest a high-risk situation for public shareholders approaching a liquidation risk if no deal is done by late July 2026.

What changed: Annual report on Form 10-K for fiscal year ended December 31, 2025, filed by Charlton Aria Acquisition Corporation (CHAR), a blank-check SPAC still searching for a business combination target. Trust value per share increased to $10.52 as of Dec 31, 2025 (from $10.10 at Dec 31, 2024) due to interest/dividends. Sponsor deposited $850,000 on April 24, 2026 to extend the combination deadline to July 25, 2026; a further extension to Oct 25, 2026 is possible with another deposit. A change in control of the sponsor occurred on May 13, 2025 — original shareholder Sunny Tan Kah Wei sold 100% of sponsor to Sovereign Global Trust LLC, whose sole member is Valley Point Limited, controlled by Chen Siak Chan. The CEO (Will Garner) and a director (Mark Chaney) resigned in February 2026; CFO/director Yuanmei Ma resigned March 24, 2026. Jung Min Lee was appointed CEO, chairman and acting CFO on March 26, 2026. The company received Nasdaq non-compliance notices for late filing of the 10-K and 10-Q; it has until June 15, 2026 to submit a plan. A working capital loan of up to $500,000 from sponsor was arranged on April 17, 2026. As of Dec 31, 2025, cash outside trust was only $5,135 with a working capital deficit of $185,217, raising substantial doubt about going concern. No business combination has been announced. Why it matters: Provides audited financials confirming trust value, redemption mechanics, extension status, and sponsor/management changes — all essential for evaluating redemption timing, sponsor alignment, and deal risk. The sponsor change of control and management departures signal potential shift in strategy or commitment. The going concern warning and Nasdaq listing threat increase the pressure to close a deal quickly. Investors should monitor whether another extension deposit occurs before July 25, 2026.

What changed: Current Report on Form 8-K disclosing a Nasdaq Listing Qualifications Department delisting notice and furnishing a Regulation FD press release. Mechanics: The filing confirms no alteration to the redemption calendar, trust value per share ($10.81), extension timeline, business combination progress, or sponsor conduct. Substance: As disclosed in the filing and press release executed by Chairman and Chief Executive Officer Jung Min Lee, the Company received a Nasdaq notice on May 22, 2026, citing noncompliance with Listing Rule 5250(c)(1) for the delayed filing of its Form 10-K (fiscal year ended December 31, 2025) and its Form 10-Q (quarter ended March 31, 2026). Nasdaq set a June 15, 2026, deadline to submit a compliance plan if both reports remain unfiled. If Nasdaq accepts the plan, the Company may receive a 180-calendar-day exception from the 10-K due date, extending the cure window until October 12, 2026. The Company reserves the right to appeal a rejected plan to a Hearings Panel. The press release describes the entity as a Cayman Islands blank check company targeting combinations outside industry or geographic restrictions, includes a forward-looking statements disclaimer, and lists Wilmington, Delaware as the executive contact address. Why it matters: Exchange listing compliance directly governs public market access, shareholder liquidity, and the practical feasibility of completing a deSPAC transaction before termination. The delinquent periodic reports eliminate near-term financial transparency, leaving investors unable to verify trust account interest accumulation, administrative expense drawdowns, or sponsor promissory note status. A missed June 15, 2026, filing or a subsequent Nasdaq Hearings Panel rejection would likely trigger forced delisting to an over-the-counter or alternative quotation venue, which typically compresses trading spreads, raises redemption friction, and heightens pressure to liquidate prior to the fixed October 25, 2026 deadline rather than execute a merger.

What changed: A Form 12b-25 Notification of Late Filing, classified as a routine SEC compliance exhibit, formally advising the Securities and Exchange Commission that Charlton Aria Acquisition Corporation could not submit its Form 10-Q for the quarterly period ended March 31, 2026, by the statutory deadline. Chief Executive Officer Jung Min Lee attributes the delay to the need for additional internal time to assemble information required to finalize the quarterly report, setting a new filing target at the fifth calendar day following the original due date. Under Part IV(2) of the same form, the company explicitly acknowledges it has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Neither the late-filing notification nor the admission of an unpaid 10-K mechanically modifies the publicly tracked redemption deadline of October 25, 2026, nor does it recalculate the documented trust value of $10.81 per share or suspend the timer toward mandatory liquidation. Why it matters: For investors tracking redemption windows, trust value stability, and sponsor conduct, cumulative reporting lapses increase compliance visibility and may constrain the sponsor's ability to execute a merger within the remaining timeframe. Rule 12b-25 relief prevents immediate trading halts or delisting actions for the specific quarter, but it carries no extension to the charter's business combination period and offers no protection against shareholder redemptions triggered after October 25, 2026. The filing contains zero operational substance: Chief Executive Officer Jung Min Lee makes no claims about customers, revenue, market size, strategy, technology, partnerships, or litigation, and there are no updates regarding sponsor equity allocations, lock-up terms, or changes to redemption mechanics.

What changed: Routine compliance exhibit accompanying a Schedule 13G beneficial ownership report filed May 12, 2026 by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, consisting solely of dual Powers of Attorney for internal regulatory filing authorization. Nothing bearing on redemption deadlines, trust value, extension windows, merger progress, or sponsor conduct has changed. The only update is administrative: the filers re-designated multiple named employees to act as Attorneys-in-Fact for submitting Rule 13f-1 and Regulation 13D-G reports. Executed on July 16, 2025, the instruments explicitly supersede prior authorizations dated July 29, 2024, and October 1, 2024, remain valid until July 16, 2026, and are revocable at will by the company. Why it matters: The document contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or operational personnel; no executive or sponsor made forward-looking statements. For investors tracking Charlton Aria Acquisition Corp., this filing confirms routine beneficial ownership reporting and updated internal compliance signatory authority, but provides no actionable intelligence on deal targeting, trust distribution mechanics, or shareholder redemptions.

What changed: A Form 8-K Current Report that accompanies Exhibits 10.1 and 10.2 (executed promissory note agreements) and Exhibit 99.1 (a press release), formally documenting the entry into material definitive agreements, the creation of direct financial obligations, unregistered sales of equity securities, and a Regulation FD announcement. According to Item 2.03 and the press release dated April 27, 2026, ST Sponsor II Limited deposited $850,000 into the trust account on April 24, 2026, extending the Company’s deadline to complete an initial business combination from April 25, 2026, to July 25, 2026. Per the filing, the Company issued an unsecured Extension Note for US$850,000 (dated April 23, 2026) and a Working Capital Note for up to US$500,000 (dated April 17, 2026). Chief Executive Officer Jung Min Lee confirmed that the Sponsor has already advanced approximately $263,681.50 in working capital since the IPO. The signed notes state the debt bears no interest except default accrual at the prevailing short-term U.S. Treasury Bill rate, matures on the earlier of a business combination or liquidation, and converts into private units by dividing the principal by $10.00, up to a maximum of $3,000,000 under the Prospectus. The Sponsor contractually waived all rights to the Trust Account Funds, agreeing to seek recovery only from non-trust assets upon liquidation. The filing reiterates the charter provision allowing two additional three-month extensions for $850,000 each, capped at an aggregate of $1,700,000. Why it matters: This filing materially adjusts the redemption calendar by pushing the liquidation trigger back three months to July 25, 2026, altering the timeframe in which public shareholders may exercise redemption rights before a forced dissolution deadline. It confirms continued sponsor financial engagement ($850,000 funded plus $500,000 in standby working capital credit) structured as non-dilutive senior debt, while establishing explicit conversion mechanics that allocate equity upside to the sponsor only upon a successful combination. Because the April 27, 2026 press release states the registrant remains a blank check company with search parameters limited only to a lack of industry or geographic restriction, the extension preserves strategic options rather than indicating deal execution. All monetary amounts, interest accrual triggers, conversion caps, maturity events, and waiver language derive exclusively from the Company’s 8-K text, the filed promissory note provisions, and statements attributed to CEO Jung Min Lee and the Sponsor.

What changed: A Form 8-K Current Report and accompanying press release disclosing receipt of a Nasdaq notice regarding failure to satisfy a continued listing rule. Nasdaq notified the Company on April 16, 2026, of noncompliance with Listing Rule 5250(c)(1) due to the failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The exchange granted a 60-day window, expiring June 15, 2026, to submit a plan to regain compliance. Should Nasdaq accept the plan, the Company may receive an extension of up to 180 calendar days from the original due date, moving the final compliance threshold to October 12, 2026. Why it matters: While the notice explicitly states there is no immediate effect on listing or trading and leaves the registered liquidation deadline of October 25, 2026, untouched, the missing 10-K creates opacity for shareholders tracking redemption conditions and trust preservation ahead of the statutory wind-down. Chairman and Chief Executive Officer Jung Min Lee stated the Company intends to file the Form 10-K "as promptly as possible," adding that if the filing is not made by June 15, 2026, the Company will formally submit a compliance plan with Nasdaq. Prolonged administrative noncompliance heightens secondary delisting risk, which can constrain market maker participation and unit liquidity well ahead of the redemption window, even if the Nasdaq-approved extension timeline theoretically aligns with the default termination date. No target acquisition, merger agreement, or sponsor amendment has been announced in this filing.

What changed: SEC Form 12b-25 Notification of Late Filing, officially notifying the Commission that Charlton Aria Acquisition Corporation’s Annual Report on Form 10-K for the period ended December 31, 2025, will miss its statutory submission window. As a procedural compliance filing, this document establishes that the company could not file the annual report without incurring 'undue hardship and expense' because it needs additional time to 'work internally to assemble certain information.' Chief Executive Officer Jung Min Lee certifies the company will submit the Form 10-K no later than the fifteenth calendar day following the prescribed due date and confirms all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 were timely. In terms of SPAC mechanics, the filing does not propose a trust extension, does not trigger redemption adjustments, and leaves the $10.81 trust per share and the 2026-10-25 business combination deadline completely unchanged. Management further states no anticipated significant change in results of operations will be reflected in the subject report. Why it matters: Administrative delays in finalizing annual financials do not alter the redemption calendar or trust valuation, but they can signal internal accounting bottlenecks, deferred auditor reviews, or ongoing resource constraints while the SPAC remains in SEARCHING status. Because this is purely a late-filing notification, it contains zero substantive commercial disclosures: there are no claims about customers, revenue streams, addressable market size, acquisition targets, technology pipelines, strategic partnerships, litigation exposure, or sponsor governance metrics. The only operational takeaway is executive acknowledgment of internal assembly delays and a commitment to near-term compliance. Investors must await the actual 10-K contents to verify cash positions, related-party transaction disclosures, and audit readiness as the company navigates toward its October 25, 2026 sunset deadline.